In this issue:
Repeat serological ACPA testing after starting therapy in seronegative RA
Cervical spine involvement in treat-to-target RA strategy
Secukinumab vs. alternative anti-TNF in axial spondyloarthritis after prior TNF inhibitor
Cartilage loss and OA pain
Methotrexate for extending TNF inhibitor survival in elderly RA patients
Tapering towards DMARD-free remission in established RA
VTE incidence following NSAID initiation in women
Reasons for stopping biologic/targeted synthetic DMARDs, and persistence of second-line RA treatment
Demographic characteristics and noninflammatory complaints in RA in remission
Long-term, real-world safety of adalimumab in RA
Please login below to download this issue (PDF)